Please assess the completion status of the following clinical trial:

Trial Title: Dietary Nitrate Supplements and Ischemic Stroke Recovery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients 18 years old and over~* Diagnosed with an ischemic stroke (acute focal neurological deficit resulting from an ischemic cause, verified by CT or MRI)~* Symptom onset within 5 days of admission~* National Institutes of Health Stroke Scale Score of 2 or more (but less than 20)~* A rating of fair or good on static sitting balance scale on a global balance scale~* A score of more that 0 on the hip flexion on the short Fugl-Myer~* Passed dysphagia screening for unrestricted or thickened liquids~Exclusion Criteria:~* Patients with severe stroke (National Institutes of Health Stroke Scale Score of 20 or more)~* A score of 0 on hip flexion on the Short Fugl-Myer as a result of weakness from the stroke~* A rating of poor on static sitting balance scale on a global balance scale~* Patients who received intravenous or intra-arterial recombinant tissue plasminogen activator (rtPA)~* Patients who are receiving citicoline~* Patients who have had a hemorrhagic stroke (including intraparenchymal, subarachnoid or subdural hemorrhage)~* A gait speed of more \> 0.8 m/s~* Patient with evidence of brain tumor or other psychiatric or neurological condition that would interfere with outcome measures~* Patients who will undergo carotid endarterectomy or other surgery during the study period~* Patients not living independently prior to stroke~* Survival is expected to be less than 6 months~* Any patient on organic nitrate-containing medications; some examples of the medications that are exclusions include nitroglycerin, isosorbide mononitrate, sildenafil (Viagra), and tadalafil (Cialis)~* Patients with atrophic gastritis~* Patients with hypotension (blood pressure less than 100/60 mmHg)~* Patients who do not pass the dysphagia screening test

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Beet It Beetroot Juice (Type: EXPERIMENTAL): 70 cc (3.8 millimoles nitrate) Beet It organic beetroot juice once a day for 30 days. Vitamin C 500 mg (tablets) will be given along with each dose of the juice.
- Beet It Beetroot Juice Placebo (Type: PLACEBO_COMPARATOR): 70 cc Beet It organic beetroot juice (placebo) once a day for 30 days. The placebo beet juice is identical in appearance and taste with nitrate removed. Vitamin C 500 mg (tablets) will be given along with each dose of the juice.Beet It Placebo Beetroot juice.

Based on this trial design, predict the completion outcome and termination type (if applicable).